TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
YARW

Yarrow Bioscience Inc

Healthcare · Biotechnology

18.80$ +0.2% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Yarrow Bioscience Inc (YARW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 24 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet YARW
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 42 – – 76 67 180 167 155 140 126 114 97 79 161 131 108 94 149 134 81 67 64 55 47 41 35 25 19 98 92 87 76 67 56 45 36 30 26 24
– 32 – – 76 64 160 156 154 140 125 113 93 78 98 119 98 87 143 128 76 63 61 52 44 38 33 23 18 96 90 84 74 64 55 44 36 30 26 24
– 4.0 – – 15 10 79 74 70 50 62 65 34 31 58 97 73 58 119 103 52 42 50 43 36 31 30 21 15 31 19 30 16 20 28 22 19 24 25 23
– 31 – – 74 62 156 154 153 136 122 109 91 77 81 99 76 59 120 103 52 42 50 43 36 31 30 21 15 93 86 78 70 62 50 40 33 29 25 23
– – – – 0.5 0.8 0.2 0.1 – – – – – – 8.3 10 11 16 11 11 10 7.6 5.5 5.3 5.5 5.0 0.1 0.2 0.3 – – – – – – – – – – –
– – – – – -3.0 – – – – – – – – 3.2 5.8 6.7 7.4 8.1 8.3 8.1 7.3 – – – – – 0.1 0.1 – – – – – – – – – – –
– – – – – – – – – – – – – – 4.0 – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – 50 – – – – – – – – – – – – – – – – – – – – – – – – –
– 71 – – 124 124 15 8.7 8.1 9.6 11 12 9.6 11 91 59 58 56 56 59 22 18 8.6 6.8 6.8 9.6 8.8 7.7 7.8 9.0 8.3 12 13 15 12 5.8 4.0 2.4 1.2 1.5
– 3.9 – – 7.2 7.8 8.5 8.6 8.1 9.5 11 12 9.5 11 57 24 23 22 22 58 21 18 8.6 6.8 6.8 9.3 7.5 6.4 6.4 7.5 6.9 12 13 15 12 5.8 4.0 2.4 1.2 1.5
– – – – – – – – – – 0.7 0.7 0.7 0.7 1.0 1.2 1.1 0.8 0.6 34 0.3 0.3 0.1 0.0 – – – – – 0.1 0.1 0.1 0.1 0.1 0.1 0.0 – – – –
– 1.5 – – 3.5 2.5 3.5 5.1 2.7 3.3 3.8 4.7 3.0 3.8 14 10.0 4.6 4.8 3.5 10 7.6 6.5 3.6 1.4 2.5 2.4 2.2 1.2 0.7 1.7 2.8 4.5 4.0 2.7 3.5 1.4 1.2 1.0 0.3 0.6
– -29 – – -48 -57 166 158 147 130 116 102 87 69 70 72 50 37 93 75 59 49 56 48 40 31 26 17 12 89 83 75 64 52 44 39 32 28 25 22
– -30 – – -50 -59 -72 -80 -93 -111 -130 -146 -163 -184 -351 -518 -543 -566 -587 -607 -628 -640 -635 -643 -653 -663 -669 -679 -685 -691 -698 -707 -719 -731 -740 -746 -753 -758 -761 -764
0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.7 0.9 0.9

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?